Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience

Leuk Lymphoma. 2017 Mar;58(3):740-742. doi: 10.1080/10428194.2016.1211280. Epub 2016 Jul 25.

Authors

Mazyar Shadman^{1

2}, Sangeeta Hingorani^{1

3}, Scott A Lanum⁴, John M Pagel^{1

2}, Rainer Storb^{1

2}, David G Maloney^{1

2}, Brenda M Sandmaier^{1

2}

Affiliations

¹ a Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.
² b Department of Medicine , University of Washington , Seattle , WA , USA.
³ c Department of Pediatrics , University of Washington , Seattle , WA , USA.
⁴ d Department of Pharmacy , University of Washington , Seattle , WA , USA.

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Female
Graft vs Host Disease / etiology
Hematopoietic Stem Cell Transplantation* / adverse effects
Hematopoietic Stem Cell Transplantation* / methods
Humans
Kidney Failure, Chronic / diagnosis
Kidney Failure, Chronic / etiology
Kidney Failure, Chronic / therapy*
Male
Middle Aged
Renal Dialysis*
Transplantation, Homologous
Treatment Outcome
Young Adult

Grants and funding